Stay updated on Elranatamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page
- Check5 days agoChange DetectedRemoved the core disease term 'Multiple myeloma' and a related MedlinePlus Genetics topic, reducing essential context about the study's focus.SummaryDifference0.1%

- Check12 days agoChange DetectedAdded topic tags for 'Multiple myeloma' and the related topic 'MedlinePlus Genetics' to the study page to improve categorization and link to educational resources.SummaryDifference0.1%

- Check19 days agoChange DetectedAdded Epworth Healthcare Richmond, Richmond, Victoria, Australia as a study site. Removed Incheon, South Korea locations and associated Not yet recruiting status, along with several related topics.SummaryDifference0.4%

- Check27 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check34 days agoChange DetectedRelated topic tags for Multiple myeloma and MedlinePlus Genetics were added, and the site revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded new recruitment sites (Meldola; Evangelismos General Hospital of Athens; Dr. Everett Chalmers Regional Hospital) and updated the total locations to 88 as of 2026-03-04, replacing the prior note of 85 locations.SummaryDifference0.4%

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.